期刊文献+

喉癌患者凝血、纤溶指标及血小板参数与术后复发的关系研究 被引量:3

下载PDF
导出
摘要 目的分析凝血、纤溶指标及血小板参数在喉癌患者中的表达水平,探讨凝血、纤溶系统与喉癌复发的关系。方法收集105例有完整病例资料及回访结果的喉癌患者,同期住院的60例喉部良性疾病患者,比较入院后次日晨起检测的凝血五项及血常规结果,分析凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)、纤维蛋白原(Fib)、D-二聚体(D-dimer),以及血小板计数(PLT)、血小板压积(PCT)、血小板分布宽度(PDW)、血小板分布体积(MPV)等指标的差异,探讨各项指标与喉癌术后复发的关系。结果 Fib、D-二聚体检测值在喉癌患者中明显高于对照组(P<0.05)。Fib、D-二聚体、PLT在Ⅲ、Ⅳ期喉癌患者中明显高于Ⅰ、Ⅱ期(P<0.05)。APTT在转移组中明显缩短于未转移组,Fib、D-二聚体、PLT在转移组中明显高于未转移组(P<0.05)。Fib、D-二聚体、PLT在喉癌复发组中明显高于未复发组差异均有统计学意义(P<0.05)。结论喉癌患者血液呈高凝状态,且存在继发纤溶亢进和血小板计数增多,这种改变与喉癌术后复发密切相关。
出处 《河北医药》 CAS 2015年第21期3271-3273,共3页 Hebei Medical Journal
  • 相关文献

参考文献8

  • 1王丽丽,徐成伟.恶性肿瘤血栓形成机制的研究进展[J].血栓与止血学,2013,19(5):237-240. 被引量:11
  • 2Bruyere F,Melen-Lamalle L,Blacher S,et al.Does plasminogen activator inhibitor-1 drive lymphangiogensis.PLo S One,2010,5:9653-9655.
  • 3Hoffmann AC,Mori R,Vallbohmer D,et al.High expression of HIFLa is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDFA,VEGF and b-FGF.Neoplasia(New York,NY),2008,10:674-679.
  • 4董伟达,李兆基,周水淼.喉癌患者手术前后凝血状态的动态观察[J].临床耳鼻咽喉科杂志,2001,15(6):258-260. 被引量:6
  • 5张月莉,梁红,沈维敏,朱砚萍,李向阳,朱惠莉,瞿介明.凝血指标与肺癌患者预后的关系[J].上海医学,2013,36(12):1031-1037. 被引量:11
  • 6Schoenleber SJ,Kurtz DM,Talwalkar JA,et al.Prognostic role of wascular endothelial growth factor in hepatocellular carcinoma:systematic review and meta analysis.Br J Cancer,2009,100:1385-1392.
  • 7Buery D,Wenz F,Groden C,at al.Tumor-platelet interaction in solid tumors.Cancer,2012,130:2747-2760.
  • 8Lee M,Kim SW,Nam EJ,et al.The impact of pretreat-ment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.Gvnecol Oncol,2011,122:238-241.

二级参考文献59

  • 1LEE AY, LEVINE MN. Venous thromboembolism and cancer: risks and outcomes [ J ]. Circulation,2003,107 : I- 17- I- 21.
  • 2KHORANA AA, FRANCIS CW, EVA CULAKOVA, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients[J]. Cancer,2007,110(10) :2339-2346.
  • 3RICKLES FR,FALANGA A. Molecular basis for the relationship between thrombosis and cancer[ J ]. Thromb Res ,2001,102 ( 6 ) : V215- 22.
  • 4FALANGA A,OFOSU FA, CORTELAZZO S, et al. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery[J]. Br J Haematol,1993,85(4) :745-750.
  • 5AY C ,SIMANEK R,VORMITTAG R,et al. High plasma levels of soluble P- selectin are predictive of venous thromboembolism in cancer patients: results from the vienna cancer and thrombosis study (CATS) [ J ]. Blood,2008,112 (7) :2703- 2708.
  • 6AY C, VORMITTAG R, DUNKLER D, et al. D- dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the vienna cancer and thrombosis study [ J ]. J Clin Oncol,2009,27 (25) :4124-4129.
  • 7FALANGA A ,TARTARI C J, MARCHETTI M. Microparticles in tumor progression[J]. Thromb Res,2012,129( Suppl 1) :S132-136.
  • 8ZWICKER JI, LIEBMAN HA, NEUBERG D,et al. Tumor- derived tissue factor-bearing microparticles are associated with venous throm-boembolie events in malignancy[J]. Clin Cancer Res, 2009, 15 (22) : 6830- 6840.
  • 9HEIT JA,SILVERSTEIN MD, MOHR DN,et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study[J]. Arch Intern Med,2000,160(6):809-815.
  • 10WUN T,WHITE RH. Epidemiology of cancer-related venous thro-mboembolism[ J]. Best Pract Res Clin Haematol,2009,22 ( 1 ) :9-23.

共引文献23

同被引文献30

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部